Akeso Biomedical, Inc. — Form D
Akeso Biomedical, Inc. of Burlington, MA, a company, filed a Form D exempt-offering notice with the SEC on 2016-03-23. The offering totals $5.0M. Industry: Other.
Offering
- Filed: 2016-03-23
- Form: D
- Accession: 0001604559-16-000002
- Industry: Other
- Exemptions: 06b
- Total offering: $5.0M
- Remaining: $5.0M
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-259858
Issuer
- Name: Akeso Biomedical, Inc.
- CIK: 0001604559
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 2400 District Avenue, Suite 110, Burlington, MA, 01803
- Phone: (781) 890-0088
Officers, directors & promoters (23)
| Name | Role | Location |
|---|
| Robert Calvin Goforth | Director | Fayetteville, AR |
| Greg W Lee | Director | Fayetteville, AR |
| Kevin Calvin Ohashi | Director | Fayetteville, AR |
| Simon Williams | Director | St Peter Port, Y7 |
| Simon Williams | Executive Officer | St Peter Port, Y7 |
| Scott J Roth | Director | Fayetteville, AR |
| Anthony J Sinskey | Director | Fayetteville, AR |
| Scott Calvin Roth | Director | Fayetteville, AR |
| Simon Calvin Williams | Director | Fayetteville, AR |
| Simon Calvin Williams | Executive Officer | Fayetteville, AR |
| Greg Calvin Lee | Director | Fayetteville, AR |
| Anthony Calvin Sinskey | Director | Fayetteville, AR |
| R. CALVIN GOFORTH | Director | FAYETTEVILLE, AR |
| Simon W Williams | Director | Burlington, MA |
| Simon W Williams | Executive Officer | Burlington, MA |
| Anthony W Sinskey | Director | Boston, MA |
| Scott W Roth | Director | Burlington, MA |
| Kevin W Ohashi | Director | Fayetteville, AR |
| Mark W Wagstaff | Executive Officer | Fayetteville, AR |
| Bernard W Prusaczyk | Director | Waltham, MA |
| Mark Calvin Kidd | Executive Officer | Fayetteville, AR |
| Bernard Calvin Prusaczyk | Director | Waltham, MA |
| Bernard Calvin Prusaczyk | Executive Officer | Waltham, MA |
Other filings by this issuer (9)
More